3Usui H, Shikata K, Matsuda M, et al. HMG-CoA reductase inhibitor ameliorates diabetic nephropathy by its pleiotropic effects in rats[J].Nephrol Dial Transplant,2003,18:265-272.
4Tonolo G, Melis MG, Formato M, et al. Additive effects of simvastatin beyond its effects on LDL cholesterol in hypertensive type 2 diabetic patients[J].Eur J Clin Invest,2000,30:980-987.
5Nagasawa K, Muraki Y, Matsuda T, et al. Inhibitory effect of statins on fetal bovine serum-induced proliferation of rat cultured mesangial cells and correlation between their inhibitory effect and transport characteristics[J].Pharm Sci,2000,89:1594-1604.
6Nabeshima K, Inui K, Uda S, et al. HMG-CoA reductase inhibitor suppression of glomerular cell proliferation in rats with anti-Thy-1.1 nephritis[J].Contrib Nephrol,1997,120:153-159.
7Vrtovsnik F, Couette S, Prie D, et al. Lovastatin-induced inhibition of renal epithelial tubular cell proliferation involves a p21ras activated, AP-1-dependent pathway[J].Kidney Int,1997,52:1016-1027.
8Kim SI, Han DC, Lee HB, et al. Lovastatin inhibits transforming growth factor-β1 expression in diabetic rat glomeruli and cultured rat mesangial cells[J].J Am Soc Nephrol,2000,11:80-87.
9Eberlein M, Heusinger-Ribeiro J, Goppelt-Struebe M, et al. Rho-dependent inhibition of the induction of connective tissue growth factor (CTGF) by HMG CoA reductase inhibitors (statins)[J].Br J Pharmacol,2001,133:1172-1180.
10Danesh FR, Sadeghi MM, Amro N, et al. 3-Hydroxy-3-methylglutaryl CoA reductase inhibitors prevent high glucose-induced proliferation of mesangial cells via modulation of Rho GTPase/p21 signaling pathway: Implications for diabetic nephropathy[J].Proc Natl Acad Sci,2002,11,99:8301-8305.
5Jo S H,Koo B K,Park J S. Prevention of radiocontrast medium-induced nephropathy using short-term high-dose simvastatin in patients with renal insufficiency undergoing coronary angiography(PROMISS)trial--a randomized controlled stud[J].American Heart Journal,2008,(03):499.
6EPSTEIN M,CAMPESE M D. Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors on renal function[J].American Journal of Kidney Diseases,2005,(01):2-14.doi:10.1053/j.ajkd.2004.08.040.
7Yokota N,O'Donel M,Daniels F. Protective effect of HMG-CoA reductase inhibitor on experimental renal ischemia-reperfusion injury[J].American Journal of Nephrology,2003,(01):13-17.
8陈汝筑;黄守坚.治疗药理学[M]北京:人民卫生出版社,2003200-204.
9ARONOV D M. Statins:therapeutic cascade of their effects[J].Kardiolo-giia,2004,(10):85-94.
10Pit B,Waters D,Brown W V. Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease Atorvastatin versus Revascularization Treatment Investigator[J].New England Journal of Medicine,1999,(02):70-76.
